Table:
begin	end	state
1	25	cytoplasmic
26	51	transmembrane
52	62	non-cytoplasmic
63	84	transmembrane
85	95	cytoplasmic
96	114	transmembrane
115	119	non-cytoplasmic
120	141	transmembrane
142	160	cytoplasmic
161	183	transmembrane
184	197	non-cytoplasmic
198	219	transmembrane
220	250	cytoplasmic
251	272	transmembrane
273	288	non-cytoplasmic
289	307	transmembrane
308	318	cytoplasmic
319	338	transmembrane
339	458	non-cytoplasmic
459	484	transmembrane
485	503	cytoplasmic
504	523	transmembrane
524	528	non-cytoplasmic
529	547	transmembrane
548	558	cytoplasmic

Input:
>PP_2569
MAVLDSTSTGSAPQRGITKEERKVIFASSLGTVFEWYDFYLYGSLAAIIARHFFAGVNET
TSFIFALLAFAAGFAVRPFGAIVFGRLGDMIGRKYTFLITIVIMGLSTAVVGLLPGYATI
GVAAPIILITLRLLQGLALGGEYGGAATYVAEHAPKGRRGFFTAWIQTTATLGLFLSLLV
IMACRTAMGTEAFEAWGWRIPFLLSILLLAISVYIRLQLNESPVFMKMKAEGKASKAPLT
ESFARWDNLKVVIMSLLGGTAGQAVVWYTGQFYALFFLLQTLKIEAQTANLLIAGSLLIG
TPFFIFFGSLSDRIGRKKIIMAGCIIAALTYFPIFKALTEYGNPDVFVAQEQNPVVVVAD
PGQCAFQFDPVGKAKFTSSCDIAKSLLAKRAIPYTNEAAEPGSVAQIRIGERVLPSFDGS
SLAAADFKVQSEAFTATLSGALKEAGYPEKADQAKIHYPMVLLLLTILVIYVTMVYGPIA
AWLVELFPARIRYTSMSLPYHIGNGWFGGFLPTVAFAMVAATGDIYYGLWYPIVIAVMTA
VLGIFFLPETKDRDITHT

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server